Press Release 858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, HR+/HER2- Unresectable or Metastatic Breast Cancer 12 minutes ago
Press Release StackAdapt’s AI Delegation Gap Report Reveals How Marketers Are Redefining AI Decision-Making in Advertising 12 minutes ago
Press Release ExchangeRight Announces Full Subscription of $26.95 Million Net-Leased All-Cash 19 DST 12 minutes ago
Press Release Kore.ai Named a Leader by Gartner, Forrester, and Everest Group Across Five Major Enterprise AI Evaluations 12 minutes ago
Press Release RockRose Risk Raises $12.5 Million Series A to Scale Vertically Integrated Wildfire-Focused Insurance Platform 12 minutes ago
Press Release The O.H.I.O. Fund Announces Lead Investment in Sonic Fire Tech’s Seed Round; Khosla Ventures Reinvests, Capping Cleveland Startup’s Seed Funding at $15M 12 minutes ago
Press Release 858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, HR+/HER2- Unresectable or Metastatic Breast Cancer 12 minutes ago
Press Release Brixton Biosciences Strengthens Board with Industry Veterans as Company Advances Towards Commercialization of Reneurx™ Nerve-Selective Therapy for Pain Associated with Knee Osteoarthritis 12 minutes ago